无标题文档

Professional team Location : Home > Professional team

  • Chen JieGeneral Manager

    With 20 years of experience in MNCs and investment sector. Previously held the positions of Business Development Director, China Head, Investment VP and Managing Director at:

    MNCs such as A.T.Kkearney, SHELL, General Electric, Philips, and Syngenta 

    CXC Capital, Managing Director ($200 million fund)

    GL Capital, Senior VP ($450 million fund)

    Olympus Capital, China Head ($1 billion fund)

    Investment Sample Cases before  bioVENTURE:

    Pharmaron (CRO), BGI (Already exit by selling old share)

    Kangchen Pharma (exited), Gan-Lee Pharma, Jingfeng Pharma (IPO)

    Arrail Dental, Zhejiang Kangning Hospital (IPO)

    HC SemiTek (Listed company code: 300323)

    MBA from Cornell University (US); Bachelor  from Zhongshan University


  • Lin YiPartner

    • Biology professional background, has many years of successful investment and entrepreneurial experience and management experience in medicine and medical equipment investment fund, served as the International Fund for China Partner, Executive Director, co-founder of the American consulting company consultant. used to be:
    • Founder Korea Investment Managing Director
    • One US Kaplan Fund Chinese partner
    • integrate capital, Mingly China Growth Fund Executive Director
    • Dongsheng Biological Technology Innovation co-founder of company directors
    • senior consultant at McKinsey & Company
    • Investment Case
    • Drug Discovery: Rongchang pharmaceutical, biological Paige Actis Pharma, US Sorrento Pharmaceuticals (Nasdaq: SRNE)
    • Medical Services: iKang (transfer exit), China Medical Network (transfer exit), United Rieger, wonderful health
    • Medical Devices: rehabilitation home (partial transfer exit), AMS (transfer exit), Munster medical, biological Yongyuan
    • Other: sweet Pu Technology (Listed Company acquired 1,000X), Duarte automobile (three new board transfer exit), net source of (three new board), Wo core technology, Choi said
    • PhD in Molecular Biology, School of Medicine, Columbia University, an MBA from the University of Chicago, Department of Biology, Peking University bachelor's degree

  • Wang ShengPartner

    • Engineering background
    University of Chicago Booth School of Business
    Margaret University Master
    Bachelor of Engineering, Zhejiang University
    Years of experience in Medtronic, experience in R & D, product and strategic planning of medical devices
    Served as: Medtronic - chief strategic alliance chief representative
    Medtronic - Greater China Business Development Director
    Medtronic - R & D Team Management Leadership
    Medtronic - Market Product Manager
    • During the Medtronic period, we have developed research, development and marketing of multiple products, and have a forward-looking understanding of the medical device industry
    • Responsible for managing mergers and acquisitions, strategic cooperation, joint ventures, minority equity investment, technology transfer and divestiture. It has unique insights into strategic planning and execution. It has played a central role in Medtronic's first strategic alliance, Coordination of various aspects of cooperation

  • Gao Jian NINGInvestment Manager

    MSc in Organic Chemistry from Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences;  BSc in Pharmaceutical Engineering from China Pharmaceutical University. 

    Previous work experience includes Nanjing Baojun Capital as Analyst, and Basilea (China) as medicinal chemist. 


  • HuWeiBinDr. investment manager

    Virology of the Pasteur Institute, Shanghai Institute of science, Chinese Academy of Sciences, biology science, China Agricultural University, Bachelor of Science
    He worked as a product manager in Abbott diagnostics central marketing department, managing Abbott's most important infectious disease product line, responsible for market research, competition analysis, new product launch, marketing and academic support.
    He worked as a product manager in the Department of diagnostics market. He was mainly responsible for the infectious disease product line. During the period of his stay, the sales compound growth rate was over 90%, and dozens of large exhibitions and academic conferences were organized.
    Served as the applied scientist in the Life Sciences Department of Thermo Fisher Scientific, responsible for the Hyclone (cell), Dharmacon/Open (Biosystems gene), Pierce (protein) technology brand

  • QianQiDr. investment manager

    Peking University, Bachelor of chemistry, The University of British Columbia, Ph. D.In Shanghai Jiading incubation center investment department as assistant investment manager in a number of start-up companies roadshow, analysis of the more than 10 parts of the business plan according to the company's industry development potential and detect the value of investment project.As a postdoctoral scholar at the University of California at Riverside, he conducted a large number of independent industry research and Analysis on new issues, and understood and designed reasonable experimental methods

  • Gao YaInvestment manager

    • Gao Ya - Investment Manager, UK Imperial College of Quantitative Biology - Master, XJTLU Biology - Bachelor
    He has been a medical and health project manager in Shanghai Fangchuang Financial Services Co., Ltd., responsible for the information collection, evaluation and feasibility study of the project. It is responsible for more than 20 project research and promotion and liaising with hundreds of investment institutions
    • Shanghai WuXi PharmaTech Pharmaceutical Development Co., Ltd. as a researcher, led the team to complete two domestic projects and three foreign projects of biological agents prescription R & D and pilot production, GMP production technology transfer matters related to the project IND declaration
    • Joined Yuansheng Venture in October 2016 as an investment manager

  • YangwenyangInvestment analyst, Fudan University pharmaceutical - Bachelor

    • Has served as a senior analyst at evalueserve business consulting, research work for the health care industry, involving many fields of medicine, medical equipment, medical services, health management, etc.
    • Fosun Group has served the star health, participate in the creation of a large health platform, commitment to business operations, product development and group health care resources integration work

  • Yan HaoInvestment manager

    ● Fudan University Medical College - Master of internal medicine, Fudan University medical school - Bachelor
    ● At OLYMPUS strategic marketing department, I was responsible for the surgical laparoscopic urology product line, product strategy positioning, new product launch, market research, important KOL maintenance and product related activities promotion.
    ● Used as a sales management trainee in the Department of minimally invasive surgery of Johnson medical equipment. It is responsible for the academic promotion of minimally invasive products and the promotion of new techniques.